BAT Non-Executive Director Joins Lanxess Supervisory Board
Uta Kemmerich-Keil, a non-executive director at British American Tobacco (BAT), has been appointed to the supervisory board of Lanxess A.G., a German chemicals company. This move is expected to broaden BAT’s strategic insights by exposing it to wider European corporate dynamics and enhancing its international corporate network. While not directly impacting BAT's operations, it may influence boardroom perspectives on risk management and market dynamics.
MAY 19·Stock Titan→
[6-K] British American Tobacco p.l.c. Current Report (Foreign Issuer) | BTI SEC Filing - Form 6-K
British American Tobacco p.l.c. (BTI) filed a Form 6-K Current Report with the SEC on May 18, 2026. This report includes a press release dated May 18, 2026, detailing notifications and public disclosures of transactions by persons discharging managerial responsibilities and persons closely associated with them. The filing indicates the company continues to meet its reporting obligations as a foreign private issuer.
MAY 16·AD HOC NEWS▼
British American Tobacco plc stock (GB0009252882): Q1 2026 miss and Goldman Sachs target cut keep outlook in focus
British American Tobacco (BAT) faced pressure after missing its Q1 2026 forecasts and a subsequent price target cut by Goldman Sachs, which maintained a Neutral rating. The article highlights how slower growth and regulatory challenges are impacting sentiment for the tobacco giant. Investors are now scrutinizing BAT's long-term cash generation, regulatory risks, and its strategy for reduced-risk products.
